Edwyn

Edwyn Search companies, tickers, CIKs…⌘K

BRISTOL MYERS SQUIBB CO

BMYCIK 0000014272Pharmaceuticals

Compare:PFE MRK ABBV LLY AMGN GILD

Compare BMY

Intrinsic Value

BMY Intrinsic Valuation

Review the filing-backed discounted cash flow baseline, scenario range, and capital structure context for a fundamentals-first fair value read.

Intrinsic Value

BMY Intrinsic Valuation

Review the filing-backed discounted cash flow baseline, scenario range, and capital structure context for a fundamentals-first fair value read.

Intrinsic value

Filing-backed DCF baseline

Automated free-cash-flow DCF baseline for BRISTOL MYERS SQUIBB CO, derived from annual filing data.

Read the DCF guide

DCF fair value

$61.69

Implied equity value $126B

Current price

—

Latest available quote for the primary listing.

Margin of safety

N/A

Live market price unavailable. Refreshing the route will retry the quote.

Fair value range

$50.67 – $77.14

Bear

$50.67

Base

$61.69

Bull

$77.14

Model assumptions

Cash flow base

$13B

Basis

Operating cash flow less capex (firm-value proxy)

Growth

1.4%

Discount

10.5%

Terminal

2.5%

Horizon

Assumption sensitivity

vs base per share

Base case$61.69Baseline

Growth +1 pt$63.42+$1.73

Intrinsic value

Filing-backed DCF baseline

Automated free-cash-flow DCF baseline for BRISTOL MYERS SQUIBB CO, derived from annual filing data.

Read the DCF guide

DCF fair value

$61.69

Implied equity value $126B

Current price

—

Latest available quote for the primary listing.

Margin of safety

N/A

Live market price unavailable. Refreshing the route will retry the quote.

Fair value range

$50.67 – $77.14

Bear

$50.67

Base

$61.69

Bull

$77.14

Model assumptions

Cash flow base

$13B

Basis

Operating cash flow less capex (firm-value proxy)

Growth

1.4%

Discount

10.5%

Terminal

2.5%

Horizon

Assumption sensitivity

vs base per share

Base case$61.69Baseline

Growth +1 pt$63.42+$1.73

What the market is pricing in

Market expectations cannot be backed out until price, share count, cash-flow base, discount rate, terminal growth, and the EV-to-equity bridge are all available.
Growth anchor: Median of 3Y revenue CAGR, 5Y revenue CAGR, and 5Y free cash flow CAGR. Scenario-derived from +/-2 pts growth and +/-1 pt discount.
Net debt reduces equity value relative to firm value before the per-share target is calculated.

Intrinsic EV-to-equity bridge

Enterprise value

Discounted free cash flows

$161B

Less total debt

− $45B

Plus cash and equivalents

+ $10B

Equity value

After the bridge

$126B

Diluted shares

2,039,000,000

Fair value / share

$61.69